Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. - Wikidata - awgldk - TriplyDB

Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.

Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.

http://www.wikidata.org/entity/Q42997283

about

Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection.Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women.Expanded criteria donors.PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.Evolving epidemiology of hepatitis C virus in the United States.The Alphabet Soup of HIV Reservoir Markers.Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale.Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testing.Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western Greece.Comparative analysis of triplex nucleic acid test assays in United States blood donors.Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 thr Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.

P2860

Q30407004-F364FF17-945F-48CF-9277-261DBD63390F Q33575261-D11A6F60-B274-439F-81B5-37F236FECF94 Q33882186-D3279170-C95A-48BE-9829-3918710291D7 Q34101320-8AA7B062-0925-4F90-A072-AEB525B87708 Q34699130-E9451DE2-C5F5-4D6E-BFF6-B9FE5F5F14DF Q34720281-5679CCA5-B692-4C56-9542-D53F5C398287 Q36058580-C6628939-63B7-4361-B3D0-AAEEB7C5BB7D Q36252455-02E0595E-B630-4FA0-9AE2-5469D8609C1C Q36281101-18A6DE8A-FB1C-4A81-947C-F5FEC9124315 Q36733650-C32103C2-1BAC-422A-A5DC-D3838ED70410 Q36909187-A21FF7FE-BCA4-4121-9E93-6CDD6C3254E0 Q37033224-AA4892CB-C6A5-40B0-9725-321F503DBA75 Q37308125-8361E3CC-1C80-4016-93A6-53A5299A0C77 Q38020157-0130BFF7-FEFA-465C-8EF3-B83553265291 Q39237000-9E516887-5184-4963-A893-DA1FDFA17B65 Q39765312-28241B94-7E21-4916-96E8-EF78DF3B8029 Q40109325-E52F45D5-F909-4062-8ADC-D8A525D2E194 Q41258015-343502D4-1A7A-4BBE-96DA-BDDD38A18FB5 Q42203091-3EE0A190-E906-4696-AA88-38DEE6601AFB Q42977683-09FDB94A-97CC-42BF-8BA7-C109880F0CEE Q42990781-17E293AB-7EE1-4711-8F52-73628478253C Q43040836-6C68547E-8447-481B-9E76-0A68D5C90BDB Q45401515-E41C5762-DA2B-4131-B5A7-EE7D9A6E5CFF Q48081521-87E6A427-A59B-4189-98EF-19385BC6C6F4

P2860

Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.

http://www.wikidata.org/entity/Q42997283

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Relative sensitivities of lice ...... d hepatitis C virus infection.

@en

Relative sensitivities of lice ...... d hepatitis C virus infection.

@nl

type

label

Relative sensitivities of lice ...... d hepatitis C virus infection.

@en

Relative sensitivities of lice ...... d hepatitis C virus infection.

@nl

prefLabel

Relative sensitivities of lice ...... d hepatitis C virus infection.

@en

Relative sensitivities of lice ...... d hepatitis C virus infection.

@nl

P1433

Q42997283-C95262E3-B7D7-4269-B478-49FB0CC7CD79

P1476

Q42997283-38E1D7E9-BD72-4683-A76C-7A903019F894

P2093

Q42997283-1EBF4B0F-CCD0-4A47-B5CD-57C2BB5C47B0

Q42997283-5A13D2A5-8F7E-44AC-8051-F3D5DBBFB56D

Q42997283-5E34C172-C565-41AA-9275-87A7D7CA9DCA

Q42997283-668704D6-501F-4250-99B4-7C86CDBCC890

Q42997283-A2B06287-C094-4088-820C-0C30D2F56B5F

Q42997283-A4099E1A-00A9-4682-9466-E0E4D0E2591C

Q42997283-A9E820E3-6AA9-4374-AF0A-1D88466F180A

Q42997283-AB802198-2A34-495F-9CED-83EF00278865

Q42997283-B7FA679F-D336-484E-8B3E-B25E692407FF

Q42997283-BE7C3488-9C04-42A2-BD72-6F3EADFF30EC

P2860

Q42997283-0A1432EC-EA51-4574-8421-6F0B11113C26

Q42997283-16D97C7A-C149-4A46-BFFD-A926540B1392

Q42997283-2F490712-2DCF-4B87-A4B1-F5F203DE3278

Q42997283-350901F7-9F70-4666-AE0E-5961867C813D

Q42997283-354640F2-3575-404F-AB91-9603F1D13BCB

Q42997283-425CC0F2-1749-4CD6-9CE1-0FBB248E5D3B

Q42997283-4375AEF5-9C3D-454D-A588-976C36C62608

Q42997283-535B6A54-1DC6-40EF-B76D-29CCBBA7D7F4

Q42997283-58C8986A-A0A6-4AB9-9BEB-E1F59EC5BF4E

Q42997283-7B86DD41-A0C6-4B12-BEC0-F34DFD2EA306

P304

Q42997283-0EE8BE69-7EFC-4E3B-98FD-5717902DEF63

P31

Q42997283-C1F000E6-22EE-48D6-88D5-5BB1BBD36E8F

P356

Q42997283-35ACEF1E-AD69-4891-A40D-9BD503F5BD65

P433

Q42997283-62CAF048-4083-4A01-A1A2-3E35E01B9D6A

P478

Q42997283-7B0F589D-4F3A-4598-B189-D8FC6D7857E3

P50

Q42997283-05E66FED-32D9-4911-9B4F-1D08B509515F

P577

Q42997283-C293C6D1-DCC9-40E4-96B0-45F7C8E877CF

P5875

Q42997283-48E0EC5B-34C7-4C89-B759-0076EB45A67A

P698

Q42997283-5B4C136C-1878-4A35-9A47-FA4BA0AE6027

P356

J.1537-2995.2005.00649.X

P1433

P1476

Relative sensitivities of lice ...... d hepatitis C virus infection.

@en

P2093

Cristina Giachetti

http://www.w3.org/2001/XMLSchema#string

Dale Hirschkorn

http://www.w3.org/2001/XMLSchema#string

David J Wright

http://www.w3.org/2001/XMLSchema#string

James Gallarda

http://www.w3.org/2001/XMLSchema#string

Joan McAuley

http://www.w3.org/2001/XMLSchema#string

John Heitman

http://www.w3.org/2001/XMLSchema#string

Megan E Laycock

http://www.w3.org/2001/XMLSchema#string

National Heart, Lung, Blood Institute Nucleic Acid Test Study Group*

http://www.w3.org/2001/XMLSchema#string

Simone A Glynn

http://www.w3.org/2001/XMLSchema#string

Steven H Kleinman

http://www.w3.org/2001/XMLSchema#string

P2860

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.

Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor.

NAT of the United States and Canadian blood supply.

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Nucleic acid amplification technology methods used in blood donor screening.

Viral diagnostics in the arena of blood donor screening.

Emerging infections, transfusion safety, and epidemiology.

Blood screening by nucleic acid amplification technology: current issues, future challenges.

Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay.

P304

1853-1863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1537-2995.2005.00649.X

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. Busch

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7400058

http://www.w3.org/2001/XMLSchema#string

P698

16371038

http://www.w3.org/2001/XMLSchema#string